Bieri, S <br/><br/>
Primary mediastinal large B-cell lymphoma: the need for prospective controlled clinical trials.  [electronic resource] 

 -  Leukemia & lymphoma  Nov 1999 
 - 537-44 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1042-8194 
<br/><br/><label>Standard No.: </label>10.1080/10428199909169618  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Actuarial Analysis<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Bleomycin--administration & dosage<br/>Combined Modality Therapy<br/>Controlled Clinical Trials as Topic<br/>Cyclophosphamide--administration & dosage<br/>Cytarabine--administration & dosage<br/>Disease-Free Survival<br/>Doxorubicin--administration & dosage<br/>Female<br/>Humans<br/>Leucovorin--administration & dosage<br/>Lymphoma, Large B-Cell, Diffuse--drug therapy<br/>Male<br/>Mediastinal Neoplasms--drug therapy<br/>Methotrexate--administration & dosage<br/>Middle Aged<br/>Prednisone--administration & dosage<br/>Procarbazine--administration & dosage<br/>Prognosis<br/>Prospective Studies<br/>Radiotherapy, Adjuvant<br/>Randomized Controlled Trials as Topic<br/>Remission Induction<br/>Thymus Neoplasms--drug therapy<br/>Treatment Outcome<br/>Vincristine--administration & dosage